About
|
HaemoScan is an independent research laboratory and testing facility specialized in blood compatibility and organ and tissue damage. Furthermore, we are specialized in (safety) testing of medical devices and new drug candidates that come into contact with blood. HaemoScan acts as a bridge between high-tech development in fundamental science and the need for support in characterizing and under-standing the (pre)clinical outcome of external and internal influences on the human body. We offer highly specialized experience in laboratory work and clinical trial support. We develop new methods and design new test kits based on these methods.
Haemoscan aspires efficiency and flexibility and distinguishes itself by offering more than standard testing. We think along with our clients to improve further development.
|
|
|
|
Dr. Willem van OeverenWim van Oeveren is chief executive officer and also owner of HaemoScan. He obtained his MSc in medical Biology and his PhD in medical sciences. Following his PhD he was the head of the blood interaction research (BIR) laboratory at the University Medical Centre Groningen. As an associate professor he has guided more than 20 PhD students. W van Oeveren is an expert in haemocompatibility research and is nominated by the Dutch normalization institute as representative for the Technical Comittee ISO/TC 194 who prepares the International Standard ISO10993/4.
|
|
Ir. Gerwin EngelsThe function chief operating officer is accomplished by G.E. Engels. Mr. Engels joined HaemoScan in October 2007. He has a background in Mechanical Engineering and Biomedical Engineering and is currently finishing his PhD in medical sciences. Besides being responsible for the daily operation of the company he is a senior scientist at HaemoScan.
|
